Neurology
Actinogen finishes enrolling patients in depression therapy trial
The trial enrolled 167 participants, who will receive either Xanamem or placebo alongside their existing antidepressant therapy.
The trial enrolled 167 participants, who will receive either Xanamem or placebo alongside their existing antidepressant therapy.